Diamine Oxidase

Precision Point Diagnostics' Advanced Intestinal Barrier Assessment (AIBA) takes a deep dive into intestinal barrier function. Using a collection of innovative biomarkers, this test helps clinicians determine if their patients have intestinal permeability, or “leaky gut.” Intestinal permeability has been suggested as a root cause of autoimmune diseases, systemic inflammation, and food sensitivities.

Precision Point Diagnostics' Gut and Detox Assessment Profile (G-DAP) screens for several of the most significant markers of leaky gut, detoxification, cardiovascular disease, cancer prevention, and dementia to provide a quick assessment of a patient's health.

This panel integrates the Advanced Intestinal Barrier Assessment (AIBA) with the P88 Dietary Antigen Test to provide a thorough evaluation of gut health and its potential triggers. The AIBA offers a detailed analysis of intestinal permeability, a key factor in systemic inflammation and autoimmune conditions, while the P88 identifies specific food sensitivities and allergies through antibody and complement analysis. This combined approach allows for targeted interventions to address both the integrity of the intestinal barrier and the dietary factors contributing to gut dysfunction and related systemic issues.

This panel integrates four key assessments to provide a holistic view of a patient's gut, oxidative stress, and adrenal health. It combines the Advanced Intestinal Barrier Assessment (AIBA) and P88 Dietary Antigen Test to evaluate intestinal permeability and food sensitivities, the Advanced Oxidative Stress profile to quantify oxidative damage and antioxidant status, and the Advanced Adrenal Stress Test to assess diurnal cortisol patterns and adrenal function. This multi-faceted approach allows for targeted interventions to address underlying imbalances contributing to a wide range of chronic conditions, including autoimmune disorders, inflammatory diseases, fatigue, and metabolic dysfunction.